TABLE 4.

Cross-distribution of azole congener MICs^a

Drug	MIC (μg/ml)	No. of isolates with MIC combination
		VOR MIC (μg/ml)											POS MIC (μg/ml)
		0.03	0.06	0.13	0.25	0.5	1	2	4	8	16	>16	0.03	0.06	0.13	0.25	0.5	1	2	4	8	16	>16
FLU	0.13	191	5	1	1		1	1
	0.25	368	15	3	2	2	2		1			5
	0.5	293	53	9	3	3	2	1	1	1	1	3
	1	182	46	26	5	3		2		3	1	4
	2	60	27	20	5	3		1	1		2	3
	4	14	30	43	25	4	4		1	1	1	2
	8	6	15	55	66	35	5	4				1
	16	2	3	8	25	48	35	2	1
	32	3	2	4	21	15	27	5	1	1	2
	64	5			4	13	3	9	2	1
	>64	14	2	2	1	3	9	7	16	11	2	17
ITR	0.03												374	17	1		1		1				1
	0.06												296	160	29	5	3	2	1	2	1		1
	0.13												116	109	27	10	6			1
	0.25												24	76	52	31	17	6		1
	0.5												8	23	17	59	109	42	8	3	1		2
	1												3	2	5	7	50	80	23	3
	2												7	2	3	4	10	23	28	4	2		4
	4												1	2	1	1	2	20	17	2	1		3
	8															1		2	2	2		1
	16															1		2	2	2		1
	>16												4	1		2			5	6	4		12

^aDistribution of VOR MICs by FLU MICs (r² = 0.48) and POS MICs by ITR MICs (r² = 0.65). All MICs are MIC-2 at 48 h.